v. 13 – 2020/01
|Market Executive Summary||Focus in Austrasia has been primarily on Blood products, transitioning to GS1 standard but is now progressing to extend to all medicines:
The Therapeutic Goods Administration (TGA) issued requirements to be placed upon blood and blood products which included item level serialization. The requirements placed upon blood products evolved to result in labelling changes to prescription pharmaceuticals with the objectives to:
Serialization requirements are not being placed upon OTC and prescription medicines however it is mandated that a machine-readable GS1 code (i.e. EAN-13 or GS1 2D DataMatrix) is applied to prescription pharmaceuticals after 1 Sept. 2020. EAN-13 is already being applied to sales packs. It is not specified that prescription medicines must be individually serialized however by applying the GS1 2D DataMatrix, GS1 and TGA are encouraging pharmaceutical companies to serialize individual sales packs.
|Key Dates||Blood Products